Combined spinal-epidural and single-shot spinal anaesthesia are both used for caesarean section. It has been claimed in individual trials that combined spinal-epidural is associated with higher sensory spread and greater cardiovascular stability. We set out to gather all available evidence. We performed: a systematic literature search to identify randomised controlled trials comparing combined spinal-epidural with spinal anaesthesia for caesarean section: conventional meta-analysis; trial-sequential analysis; and assessment of trial quality using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Fifteen trials with high heterogeneity, including 1015 patients, were analysed. There was no significant difference between combined spinal-epidural and spinal anaesthesia for our primary outcomes maximum sensory height and vasopressor use (mg ephedrine equivalents). However, trialsequential analysis suggested insufficient data and the GRADE scores showed 'very low' quality of evidence for these outcomes. The secondary outcomes hypotension, time for sensory block to recede to the level of T10, and the combined outcome of nausea and vomiting, did not differ significantly between the interventions. The block times were statistically significantly longer for combined spinal-epidural in individual trials, but only one trial showed a clinically meaningful difference (11 min). Based on this analysis, and taking into consideration all comparisons irrespective of whether drugs had been applied via the epidural route, there is not enough evidence to postulate any advantage compared with the spinal technique. Future analyses and studies need to examine the potential advantages of the combined spinal-epidural technique by using the epidural route intra-and/or postoperatively.
Introduction
Caesarean section should whenever possible be performed under neuraxial anaesthesia. Combined spinalepidural and single-shot spinal anaesthesia are both used. Combined spinal-epidural has gained some popularity in recent years as intra-operative anaesthesia can be continued postoperatively by giving drugs through the epidural catheter [1] . However, the possible benefits of combined spinal-epidural over spinal anaesthesia are the subject of fierce debate [2, 3] . There are authors who have speculated that combined spinalepidural is associated with a higher cephalad extension of the sensory block [4] , although this was not corroborated in another study [5] . Similarly, there are conflicting results in the literature concerning the two techniques' effects on hypotension and vasopressor requirement [6, 7] . We set out to retrieve reports comparing the two techniques in a randomised way. The extracted data were subjected to conventional metaanalysis, followed by trial-sequential analyses, that aimed to assess whether the available body of evidence is sufficient to allow definitive conclusions.
Methods
Our meta-analysis was performed in accordance with the PRISMA statement [8] .
The databases Medline Epub, Embase, Google Scholar, Web of Science, and Cochrane Central were searched on 26 April 2017. We searched for trials that compared combined spinal-epidural with spinal anaesthesia in parturients undergoing caesarean section. The detailed search strategy for the various databases is available in the Supporting Information. Our primary outcomes were the maximum sensory height, and vasopressor use; our secondary outcomes were hypotension, time to maximum sensory block, time for sensory block to recede, time to maximum motor block, time for motor block to recede, nausea and vomiting.
We excluded retrospective studies, case-reports, non-randomised studies and studies in which epidural volume extension was done in the combined spinalepidural group.
For continuous variables, mean and standard deviations were extracted or, if not given, calculated from median and range using the formula published by Hozo et al. [9] . For our primary outcome, vasopressor use, we calculated the ephedrine equivalents given in milligrams. If phenylephrine was used as a vasopressor, we calculated the ephedrine equivalent based on an assumed equipotency of 8 mg ephedrine to 100 lg phenylephrine [10, 11] .
We combined binary data by simple addition; for the combination of continuous variables the formula described by the Cochrane Collaboration was used [12] .
For our analyses of sensory or motor block height we assigned the number 1 for the first thoracic segment (T1), 2 for the second (T2) and so on up to the twelfth segment (T12). For the cervical segments we assigned the number À1 to C8, À2 for C7 and so on. Likewise, L1 was assigned the number 13, L2 the number 14 and so on.
We used the Cochrane Collaboration's tool for assessing risk of bias [12] . The risk of selection, performance, detection, attrition, reporting biases and other biases, were assessed. We contacted the corresponding author of a study if there were questions about one of these domains. Our meta-analysis compared a catheter with a single-shot technique and it is therefore impossible to achieve blinding of patient or care provider or outcome assessor. We therefore included unblinded studies into our analyses that were randomised, similar to the procedure chosen in our analysis comparing combined spinal-epidural with epidural analgesia in labour [13] .
Data extraction and the assessment of risk of bias were performed independently by two authors (MH, MK). According to our protocol, discrepancies should be resolved by discussion. If this was impossible a third author was involved and a final decision made.
Data were subjected to meta-analysis if at least 100 patients per treatment arm were studied and if at least three studies were available. Risk ratios (95%CI) were calculated for dichotomous variables, and mean differences (95%CI) for continuous data. As we expected heterogeneity, the random effects model was used. To assess heterogeneity the I 2 statistic was applied [14, 15] . We considered p < 0.05 statistically significant. The software used was Review Manager (RevMan, version 5.3 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).
Asymmetry in conventional funnel plots can exist without true asymmetry, and reasons other than publication bias can result in asymmetry [16, 17] . For this reason, contour-enhanced funnel plots were performed. This was done if there were 10 or more studies in the meta-analyses of the primary outcomes [18] . We used the test described by Egger et al. [19] to test for plot asymmetry. Furthermore, similar to interim analyses of primary clinical trials, meta-analyses have been found to be prone to type-1 (falsely positive results) and type-2 error (falsely negative results) during statistical analysis [20, 21] . Trial-sequential analyses were performed for the primary outcomes of our meta-analyses, in order to consider the risk of random error and better estimate the uncertainty in our findings [22, 23] . Trial-sequential analysis are based on the cumulative Z-curve (the Z-test value at each meta-analysis update), the conventional level of significance (e.g. Z score = 1.96 for a p value threshold of 5%), the number of patients in meta-analysis, the calculated required information size, trial-sequential significance boundaries and futility boundaries. Adjustment of the thresholds for Z score based on the cumulative existing evidence allows the construction of the trialsequential significance boundaries, based on the O'Brien-Fleming alpha spending function. A cumulative Z-curve that crosses this boundary is considered to indicate a significant effect.
We calculated the required information size allowing for a type-1 error of 0.05, and type-2 error of 0.20, with the mean difference from the effect estimate from the conventional random effects model [24] , and heterogeneity estimated by the diversity (D 2 ) in the included trials. Trial-Sequential Analysis software (version 0.9 Copenhagen Trial Unit, Copenhagen, Denmark) was used.
In order to rate the quality of evidence and strength of recommendation of our primary outcomes, the Grading of Recommendations Assessment, Development, and Evaluation system (GRADE) [25] was used. We assessed the following criteria: risk of bias; inconsistency (the I 2 statistic was ≥ 50% and no satisfactory explanation by sub-group analysis/meta-regression was found); indirectness (outcome data were based on indirect comparisons of interest, on the population of interest, and on the outcome of interest (surrogate markers)); imprecision (studies included only relatively few patients and/or relatively few events, the total number of participants does not exceed the required information size and does not pass an appropriate threshold for significance or futility); and publication bias, as reflected in asymmetry of the contour-enhanced funnel plot. When one of the above items was assessed as a risk, the evidence was downgraded by two levels (very serious risk) or one level (serious risk).
For the primary outcome, one of the following four grades was finally assigned: high quality (further research is very unlikely to alter the confidence in the estimate of the effect); moderate quality (further research is likely to alter the confidence in the estimate of the effect); low quality (further research is very likely to alter the confidence in the estimate of the effect); or very low quality (the confidence in the effect estimate is very little). Figure 1 shows the flow chart of the selection of included trials. Our search identified 1426 reports, and 15 trials [4] [5] [6] [7] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] reporting on 1015 patients qualified for quantitative analysis.
Results
The assessment of the risk of bias is given in Fig. 2 . Details of the included studies are presented in Table 1 . The way combined spinal-epidural was used differed between the studies. These differences mainly related to: the choice and dose of intrathecal drugs (same for both groups, or less for combined spinalepidural); whether an epidural catheter was inserted in the combined spinal-epidural group or not: and the use of this catheter intra-and postoperatively.
The study by Ko et al. [7] had four arms: crystalloid or colloid pre-load were studied in patients undergoing combined spinal-epidural or spinal anaesthesia. We entered the data of the groups receiving crystalloid preload and those receiving colloid pre-load separately.
Kaufner et al. [34] studied two combined spinalepidural groups, one with patient-controlled epidural analgesia and the other with epidural boluses. We combined the data of these two groups. Figure 3 shows the forest plot of maximum sensory height in patients receiving combined spinalepidural vs. spinal anaesthesia. No significant difference was obtained in conventional meta-analysis, the mean difference (95%CI) being À0.72 (À1.61 to 0.17, p = 0.11). Heterogeneity was high in this analysis with I 2 = 95% (p < 0.00001) and with studies not only favouring combined spinal-epidural but also favouring spinal anaesthesia. According to our protocol, a contour-enhanced funnel plot was not done as there were fewer than 10 studies.
In trial-sequential analysis (see also Supporting Information, Fig. S1 ) the cumulative Z score did not cross the trial-sequential monitoring boundaries and did not reach the required information size of 1249.
For vasopressor use, mg ephedrine equivalents were calculated. The result of conventional meta-analysis, shown in Fig. 4 , showed that there was no significant difference between the two study arms, the mean difference (95%CI) being À0.79 mg (À2.62 to 1.03) ephedrine equivalent (p = 0392). Heterogeneity in this analysis was high (I 2 = 96%, p < 0.0001) not only in studies favouring combined spinal-epidural but also in studies favouring spinal anaesthesia.
In trial-sequential analysis of this outcome (see also Supporting Information, Fig. S2 ) the trial-sequential monitoring boundaries were not crossed and the required information size was not reached. A contourenhanced funnel plot was done (see also Supporting Information, Fig. S3 ) and Egger`s test showed a p value of 0.2363, indicating no asymmetry and no publication bias.
Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessments were made for maximum sensory height and vasopressor use. For both variables there was a serious risk of bias (no blinding of patients, outcome assessors and care providers), a serious risk of inconsistency (I 2 statistic was ≥ 50%) and a serious risk of imprecision (trialsequential analysis monitoring boundaries and required information size were not reached). In the case of vasopressor use, publication bias was unlikely (no asymmetry of the contour-enhanced funnel plot), and for maximum sensory height there were not
Records identified through database searching: n = 2751
Abstracts screened: n = 1426
Full-text articles assessed for eligibility:
Records excluded:
No spinal anaesthesia group: n = 1
Epidural volume extension performed in CSE group: n = 1
No randomisation: n = 1
Number of studies included in qualitative synthesis: n = 15
Records after duplicates removed: n = 1426
Records excluded: n = 1405 enough studies to do a contour-enhanced funnel plot. Indirectness was not relevant for either primary outcome. We therefore assigned a rating of 'very low quality' to the evidence for the outcomes maximum sensory height and vasopressor use. There were enough data for the secondary outcomes hypotension, time for sensory block to recede to T10, shivering, and the combined outcome of nausea and vomiting, to perform meta-analyses (Table 2) . No significant reduction in the risk of hypotension or in the risk of shivering in the combined spinal-epidural group was observed. A lower incidence of nausea and vomiting was found in patients receiving combined spinal-epidural than in those receiving spinal anaesthesia. For the outcome 'time for sensory block to recede to T10' there was no significant difference between the two interventions.
We also found data on the time to perform combined spinal-epidural and the time to perform spinal anaesthesia. Although we had not considered this outcome in our pre-defined protcol, we analysed those data. The definitions of these times varied among the studies, so we could not combine the data of the single studies. Time from induction of block until readiness for surgery, as reported by Macfarlane et al. [31] , was 13.3 min (median) in the combined spinal-epidural group, which was significantly longer than in the spinal group (10.6 min). The mean time from induction of block until start of surgery was significantly longer in the combined spinal-epidural group in the study by Thor en et al. [6] : 29.4 min vs. 17.8 min in the spinal group. Choi et al. [29] reported that the anaesthetic procedure time was significantly longer in the combined spinal-epidural group (mean of 4.6 min vs. 3.2 min in the spinal anaesthesia group). Furthermore, Ross et al. [33] studied obese parturients and concluded that the combined spinal-epidural was not inferior to the spinal technique. Table S1 (see Supporting Information) shows the results of the secondary outcomes (nausea, vomiting, dizziness, pruritus, bradycardia, induction to start of surgery time, time to maximum sensory block, time to maximum motor block, time for motor block to recede to a score of 2 on the Bromage scale, time for sensory block to reach T4, complete motor block recovery ASA, American Society of Anesthesiologists physical status classification; BMI, body mass index; CSE, combined spinal-epidural analgesia; HELLP, hypertension, elevated liver enzymes, low platelets; PCEA, patient-controlled epidural analgesia; SBP, systolic blood pressure.
time) for which there were not sufficient data to do a meta-analysis, thta is, there were fewer than three studies or fewer than 100 patients per study arm.
Kilic ßkan et al. [36] reported that the overall incidence of pruritus in their study was 69.6%; the most common side-effect in the spinal groups was nausea. This table also includes the data by McAndrew and Harms [27] on paraesthesiae. Table S2 in the Supporting Information summarises the pain data. Thor en et al. [6] and Choi et al. [29] did not report differences between the combined spinal-epidural and the spinal anaesthesia group. Kaufner et al. [34] studied three postoperative pain regimens: intrathecal single-shot anaesthesia with an opioid; patient-controlled combined spinal-epidural; and epidural bolus combined spinal-epidural. Spinal single-shot scored best for postoperative pain scores; ibuprofen consumption was lower in this group than in the epidural group, and identical to the value obtained with patient-controlled combined spinal-epidural. In the spinal anaesthesia group compared with the combined spinal-epidural groups, the pain scores were lower: at 6 and 9 h postoperatively; at rest; and during mobilisation. Moreover, significantly lower pain scores were also observed at 24 h and 48 h after mobilisation. In that study, the use of ibuprofen at 24 h was significantly lower in the spinal compared with the combined spinal-epidural bolus group. The use of paracetamol was higher in the spinal compared with the combined spinal-epidural patient-controlled epidural analgesia group at 24 h, whereas at 48 h the opposite was true. Morphine, buprenorphine and paracetamol use at 48 h did not differ between the groups.
Discussion
We did not find evidence of a difference between combined spinal-epidural and single-shot spinal techniques for our primary outcomes maximum sensory height or vasopressor use. Trial-sequential analysis indicated a lack of evidence for both parameters. There was no sign of publication bias for the outcome vasopressor use as assessed by the contourenhanced funnel plot. GRADE scores were of 'very low quality' for the two primary outcomes. For the secondary outcomes, incidence of hypotension, nausea and vomiting, or time for sensory block to recede to T10, there was no difference in conventional metaanalyses.
These findings might be disappointing and conflicting, especially for those who consider combined spinal-epidural a superior technique compared with spinal anaesthesia in an unselected population. Indeed, previous studies have shown that low-dose spinal anaesthesia (which might be used in combined spinalepidural) produces less hypotension than 'normal' spinal anaesthesia [37] . However, the same study also demonstrated the risks of insufficient anaesthesia when performing low-dose spinal anaesthesia, which might explain why, in many of the included trials (Table 1) , equal doses of anaesthetic drugs for both techniques were used. That way, some theoretical advantages of the combined spinal-epidural are at least partially counteracted. However, we consider that the different drugs and different doses used in the included studies reflect clinical practice in various institutions. These differences in clinical practice are reflected in the high level of clinical and statistical heterogeneity. We did not perform a sub-group analysis with respect to whether the epidural catheter was used (for instance peri-operatively, postoperatively or not at all) as this analysis was not pre-specified in our protocol.
According to our pre-registered protocol, we performed trial-sequential analysis to evaluate the strength of the available evidence despite the high level of heterogeneity. Trial-sequential analysis is analogous to interim monitoring boundaries in single randomised controlled trials. Multiple testing inflates the risks of type-1 and -2 errors of statistical analysis and these risks exist both in interim analyses of single trials and in meta-analyses. Trial-sequential analysis performed for our primary outcomes was indicative of a lack of sufficient power to draw the definitive conclusion that there is an absence of difference. More data are needed, and with sufficiently-powered analysis firm conclusions will be possible. In single trials, power analysis is done a priori, usually based on a pilot study or based on data from another trial. Trial-sequential analysis is not able to give such an a priori estimate of the number of patients required to come to firm evidence before a meta-analysis is done. Each new trial that is added can change the between-trials variance and the proportion of events in the control group of a meta-analysis. These two parameters affect the required information size and the number of required future trials. We have to be aware that our study thus does not provide the basis for the planning of the population size of future trials.
Our analysis revealed a significantly longer time needed to perform the combined spinal-epidural compared with the spinal block. However, although statistical significance was found in all three studies [6, 29, 31] only the time from induction of block until start of surgery in the study by Thor en et al. [6] is clinically relevant.
We have to acknowledge limitations in our analysis. First, weaknesses of our meta-analysis are linked to Figure 4 Forest plot of meta-analysis of vasopressor use (mg ephedrine equivalent). Co, colloids; Cr, crystalloids; CSE, combined spinal-epidural anaesthesia; IV, inverse variance; SpA, Spinal anaesthesia. An assumed advantage of the combined spinal-epidural compared with the single-shot spinal technique is that combined spinal-epidural allows the transition from intra-operative anaesthesia to postoperative analgesia using the epidural catheter. We would expect that this would translate into a reduced need for oral or intravenous analgesics, and possibly lower pain scores, in the combined spinal-epidural group after surgery. Interestingly, there were only a few studies reporting on these outcomes. They found either no significant difference [6] or lower pain scores with spinal anaesthesia [34] . In future research, the potential benefits of a combined spina-epidural should be addressed, i.e. a fast onset of analgesia (via the spinal component) and the extension of intra-operative anaesthesia into postoperative analgesia (by intra-and postoperative use of the epidural catheter).
It is of no value to perform a more time-consuming, more invasive and more expensive technique in one group and then not to use the epidural route. This inevitably adds complexity without gaining additional benefit. Our analyses were unable to reveal differences between combined spinal-epidural and spinal anaesthesia for maximum sensory height, vasopressor use or any of the other secondary outcomes as suggested by the analysis, including all trials of which many actually did not properly use the epidural route. Sufficient data were lacking to make a conclusion whether or not a difference exists. The quality of evidence is very low according to the GRADE scores.
Our analysis compared the combined spinalepidural with the spinal technique for anaesthesia in parturients undergoing caesarean section. On a slightly different, although related note, Simmons et al. were interested in the effects of combined spinal-epidural analgesia and compared this neuraxial technique to conventional epidural analgesia in labouring women. Given that only minor differences in onset time and the incidence of pruritus were found between the two techniques, those authors concluded that no recommendation can be made in favour of combined spinalepidural analgesia [38] .
Based on our results, clinicians need to weigh the disadvantages of a technique that might be more timeconsuming, more invasive and more expensive against the benefit of having a 'rescue' option when block height is not sufficient. This is especially true if a reduction in the intrathecally administered local anaesthetic is desired. Our analysis does not support simply using the combined spinal-epidural technique without consistently exploiting its potential intra-and postoperative advantages. Future research should take this, and the various methodological shortcomings revealed by our included studies, into account. 
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